Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA's Advertising Studies Expand To Internet Spots, Disease Awareness

Executive Summary

FDA is continuing to start new studies on the format of advertising even as it prepares to release the results from previous research. While the steady drip of studies gives industry continuing opportunity to provide feedback to the agency's Division of Drug Marketing, Advertising and Communications, it also means that the findings that FDA makes, particularly on the impact of qualitative language, may be superseded by further research.

You may also be interested in...



The Drug Olympics: FDA To Test Consumer Comprehension Of Composite Endpoints

FDA will explain to study participants that just as a decathlon athlete may not win at the long jump, the shot put, or the 50-yard dash but may still be the best overall, a composite score in a clinical trial may not guarantee a drug’s efficacy against any given symptom that is a component of the whole.

FDA Advertising Studies Move Forward Along Several Broad Fronts

FDA Advertising Studies Move Forward Along Several Broad Fronts

Topics

UsernamePublicRestriction

Register

PS052695

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel